The page is the record's research on the issuer — no analyst, no rating, no view.

# Fortress Biotech, Inc. (NASDAQ: FBIO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Fortress Biotech, Inc., listed on NASDAQ under ticker FBIO, with ISIN US34960Q3074 and LEI 529900DZUWSYUURECK24. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 40 filings in the twelve months to 2026-11-08, across 23 filing days. The median gap between filing days is 13.0 days. The latest filing is dated 2026-10-29, is of type regulatory_filing, and sits 10 days before the record date. The NASDAQ median cadence gap is 6.0 days, the NASDAQ median latency is 5.0 days, and the NASDAQ median filings count is 52. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days, its median latency is 4.0 days, and its median filings count is 63.0.

## Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's own investor-relations page names three research houses: Alliance Global Partners, H.C. Wainwright and Global Partners. The count is 3.

## Open research

The record holds no openly published research notes; none was found.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001429260.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/FBIO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.fortressbiotech.com/investors/analyst-coverage (coverage)
- https://mcp.us-cm-kg.ai/record/NASDAQ/FBIO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/FBIO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp